195 related articles for article (PubMed ID: 3118512)
1. Methoxsalen decreases the metabolic activation and prevents the hepatotoxicity and nephrotoxicity of chloroform in mice.
Lettéron P; Degott C; Labbe G; Larrey D; Descatoire V; Tinel M; Pessayre D
Toxicol Appl Pharmacol; 1987 Nov; 91(2):266-73. PubMed ID: 3118512
[TBL] [Abstract][Full Text] [Related]
2. The drug methoxsalen, a suicide substrate for cytochrome P-450, decreases the metabolic activation, and prevents the hepatotoxicity, of carbon tetrachloride in mice.
Labbe G; Descatoire V; Letteron P; Degott C; Tinel M; Larrey D; Carrion-Pavlov Y; Geneve J; Amouyal G; Pessayre D
Biochem Pharmacol; 1987 Mar; 36(6):907-14. PubMed ID: 3105541
[TBL] [Abstract][Full Text] [Related]
3. Pre- or post-treatment with methoxsalen prevents the hepatotoxicity of acetaminophen in mice.
Letteron P; Descatoire V; Larrey D; DeGott C; Tinel M; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Nov; 239(2):559-67. PubMed ID: 3772810
[TBL] [Abstract][Full Text] [Related]
4. Temporal relationships between biotransformation, detoxication, and chlordecone potentiation of chloroform-induced hepatotoxicity.
Hewitt LA; Caillé G; Plaa GL
Can J Physiol Pharmacol; 1986 Apr; 64(4):477-82. PubMed ID: 2425914
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of cytochrome P-450 by the drug methoxsalen.
Fouin-Fortunet H; Tinel M; Descatoire V; Letteron P; Larrey D; Geneve J; Pessayre D
J Pharmacol Exp Ther; 1986 Jan; 236(1):237-47. PubMed ID: 3941395
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives.
Tinel M; Belghiti J; Descatoire V; Amouyal G; Letteron P; Geneve J; Larrey D; Pessayre D
Biochem Pharmacol; 1987 Mar; 36(6):951-5. PubMed ID: 3494453
[TBL] [Abstract][Full Text] [Related]
7. Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
Labbe G; Descatoire V; Beaune P; Letteron P; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1989 Sep; 250(3):1034-42. PubMed ID: 2506333
[TBL] [Abstract][Full Text] [Related]
8. Effects of methoxsalen on the metabolism of acetaminophen in humans.
Amouyal G; Larrey D; Letteron P; Geneve J; Labbe G; Belghiti J; Pessayre D
Biochem Pharmacol; 1987 Jul; 36(14):2349-52. PubMed ID: 3606645
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice.
Smith JH; Hook JB
Toxicol Appl Pharmacol; 1984 May; 73(3):511-24. PubMed ID: 6719466
[TBL] [Abstract][Full Text] [Related]
10. Chloroform toxicity in mice: correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules.
Ilett KF; Reid WD; Sipes IG; Krishna G
Exp Mol Pathol; 1973 Oct; 19(2):215-29. PubMed ID: 4754791
[No Abstract] [Full Text] [Related]
11. Effects of differential changes in rat hepatic and renal cytochrome P-450 concentrations on hepatotoxicity and nephrotoxicity of chloroform.
McMartin DN; O'Connor JA; Kaminsky LS
Res Commun Chem Pathol Pharmacol; 1981 Jan; 31(1):99-110. PubMed ID: 7255876
[TBL] [Abstract][Full Text] [Related]
12. Time dependence of chloroform-induced metabolic alterations in the liver and kidney of B6C3F1 mice.
Rossi S; Gemma S; Fabrizi L; Testai E; Vittozzi L
Arch Toxicol; 1999 Sep; 73(7):387-93. PubMed ID: 10550481
[TBL] [Abstract][Full Text] [Related]
13. Effect of polybrominated biphenyls, beta-naphthoflavone and phenobarbital on arylhydrocarbon hydroxylase activities and chloroform-induced nephrotoxicity and hepatotoxicity in male C57BL/6J and DBA/2J mice.
Ahmadizadeh M; Kuo CH; Echt R; Hook JB
Toxicology; 1984 Jun; 31(3-4):343-52. PubMed ID: 6330937
[TBL] [Abstract][Full Text] [Related]
14. Ketone potentiation of haloalkane-induced hepato- and nephrotoxicity. II. Implication of monooxygenases.
Raymond P; Plaa GL
J Toxicol Environ Health; 1995 Nov; 46(3):317-28. PubMed ID: 7473860
[TBL] [Abstract][Full Text] [Related]
15. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: utility of renal specific P450 reductase knockout mouse models.
Liu S; Yao Y; Lu S; Aldous K; Ding X; Mei C; Gu J
Toxicol Appl Pharmacol; 2013 Oct; 272(1):230-7. PubMed ID: 23732084
[TBL] [Abstract][Full Text] [Related]
16. 7-Ethoxycoumarin dealkylase and cytochrome P-450 from grey partridge (Perdix perdix) hepatic and duodenal microsomes.
Rivière JL
Biochem Biophys Res Commun; 1980 Nov; 97(2):546-52. PubMed ID: 6781496
[No Abstract] [Full Text] [Related]
17. The role of biotransformation-detoxication in acetone-, 2-butanone-, and 2-hexanone-potentiated chloroform-induced hepatotoxicity.
Hewitt LA; Valiquette C; Plaa GL
Can J Physiol Pharmacol; 1987 Nov; 65(11):2313-8. PubMed ID: 3449191
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the arachidonic acid and NADPH-dependent microsomal metabolism of naphthalene and 2-methylnaphthalene and the effect of indomethacin on the bronchiolar necrosis.
Buckpitt AR; Bahnson LS; Franklin RB
Biochem Pharmacol; 1986 Feb; 35(4):645-50. PubMed ID: 3081009
[TBL] [Abstract][Full Text] [Related]
19. Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
Lettéron P; Fouin-Fortunet H; Tinel M; Danan G; Belghiti J; Pessayre D
J Pharmacol Exp Ther; 1984 Jun; 229(3):845-50. PubMed ID: 6547179
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity and hepatotoxicity of chloroform in mice: effect of deuterium substitution.
Ahmadizadeh M; Kuo CH; Hook JB
J Toxicol Environ Health; 1981; 8(1-2):105-11. PubMed ID: 7328696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
